Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Pancreatic Cancer Resectable × Leucovorin × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 388 Rectal Neoplasms 194 Colonic Neoplasms 183 Pancreatic Neoplasms 118 Stomach Neoplasms 110 Neoplasm Metastasis 86 Neoplasms 57 Esophageal Neoplasms 54 Precursor Cell Lymphoblastic Leukemia-Lymphoma 45 Lymphoma 42 Leukemia 36 Carcinoma, Hepatocellular 36 Adenocarcinoma Of Esophagus 35 Burkitt Lymphoma 27 Adenocarcinoma 25 Cholangiocarcinoma 24 Biliary Tract Neoplasms 22 Gastrointestinal Neoplasms 19 Gallbladder Neoplasms 19 Carcinoma, Non-Small-Cell Lung 18 Lymphoma, Non-Hodgkin 16 Liver Neoplasms 14 Esophageal Squamous Cell Carcinoma 14 Bile Duct Neoplasms 14 Osteosarcoma 12 Leukemia, Myeloid, Acute 12 Unspecified Adult Solid Tumor, Protocol Specific 11 Lymphoma, Large B-Cell, Diffuse 11 Breast Neoplasms 11 Leukemia, Biphenotypic, Acute 10

Interventions

Gemcitabine 4 130-nm albumin-bound paclitaxel 2 sintilimab 1 nimotuzumab 1 avelumab 1 Taxes 1 Oxaliplatin 1 Leucovorin 1 Irinotecan 1 Hydroxychloroquine 1 Fluorouracil 1 Capecitabine 1 Antineoplastic Agents 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07155629 2025-09-04

LEFT-PANC

Helsinki University Central Hospital

Phase 3 Not yet recruiting

Gastrointestinal

Pancreatic Cancer Resectable

Data powered by HemOnc (CC BY 4.0) Colophon ⚡